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AbstrACt 
Objectives To determine the incidence of unintended 
pregnancy among female sex workers (FSWs) in low-
income and middle-income countries (LMICs).
Design We searched MEDLINE, PsychInfo, Embase and 
Popline for papers published in English between January 
2000 and January 2016, and Web of Science and Proquest 
for conference abstracts. Meta-analysis was performed on 
the primary outcomes using random effects models, with 
subgroup analysis used to explore heterogeneity.
Participants Eligible studies targeted FSWs aged 15–49 
years living or working in an LMIC.
Outcome measures Studies were eligible if they 
provided data on one of two primary outcomes: incidence 
of unintended pregnancy and incidence of pregnancy 
where intention is undefined. Secondary outcomes were 
also extracted when they were reported in included 
studies: incidence of induced abortion; incidence of birth; 
and correlates/predictors of pregnancy or unintended 
pregnancy.
results Twenty-five eligible studies were identified 
from 3866 articles. Methodological quality was low 
overall. Unintended pregnancy incidence showed high 
heterogeneity (I²>95%), ranging from 7.2 to 59.6 per 100 
person-years across 10 studies. Study design and duration 
were found to account for heterogeneity. On subgroup 
analysis, the three cohort studies in which no intervention 
was introduced had a pooled incidence of 27.1 per 100 
person-years (95% CI 24.4 to 29.8; I2=0%). Incidence 
of pregnancy (intention undefined) was also highly 
heterogeneous, ranging from 2.0 to 23.4 per 100 person-
years (15 studies).
Conclusions Of the many studies examining FSWs’ 
sexual and reproductive health in LMICs, very few 
measured pregnancy and fewer assessed pregnancy 
intention. Incidence varied widely, likely due to differences 
in study design, duration and baseline population risk, 
but was high in most studies, representing a considerable 
concern for this key population. Evidence-based 
approaches that place greater importance on unintended 
pregnancy prevention need to be incorporated into 
existing sexual and reproductive health programmes for 
FSWs.
PrOsPErO registration number CRD42016029185
IntrODuCtIOn  
Unintended pregnancy affects a large number 
of women in low-income and middle-income 
countries (LMICs) and can have significant 
impacts on maternal and child health.1–3 
Unintended pregnancy is a high priority 
issue for many female sex workers (FSWs)4 5 
who usually have dependents to support and 
for whom pregnancy may increase financial 
dependence on sex work and add to already 
high levels of stigmatisation.5 This has been 
confirmed by consultation with FSWs in 
Kenyai and workshops with FSWs to inform 
development of a pregnancy prevention inter-
vention.6 Participants expressed considerable 
i Our research group has worked closely with a local 
NGO (International Centre for Reproductive Health, 
Kenya) which has a long history of collaborating with and 
providing services for sex workers in Mombasa.
strengths and limitations of this study
 ► This is the first study to systematically review and 
analyse the incidence of pregnancy or unintended 
pregnancy among female sex workers  (FSWs) in 
low-income and middle-income countries.
 ► Broad inclusion criteria meant that the review al-
lowed for the inclusion of a large proportion of the 
studies that have collected data on pregnancy or 
unintended pregnancy rates in this population.
 ► However, limitations of broad inclusion criteria are 
that only one study had an a priori objective of mea-
suring pregnancy incidence, and studies were highly 
varied in terms of their methodology, settings and 
study populations.
 ► High heterogeneity prevented pooled analysis of all 
studies but allowed for subgroup analysis for cohort 
studies and for studies in which no intervention was 
introduced.
 ► Pregnancy rates among FSWs could not be com-
pared with the background general population rates 
because of the lack of availability of those data.
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fear and anxiety about pregnancy, related personal and 
peer experiences of pregnancy scares and emphasised 
the importance of improving knowledge of family plan-
ning in their community (unpublished qualitative data, 
Mombasa, Kenya).
FSWs can face elevated risks of unintended pregnancy 
due to a high frequency of intercourse and a high number 
of sexual partners.7 8 Risks are exacerbated by concur-
rent paying and non-paying partnerships8 and by sexual 
and gender-based violence, gender inequalities and 
stigma towards sex work, which reduce women’s power 
to negotiate within sexual relationships.9–11 While gains 
have been made in terms of condom use with paying 
clients,12 rates of condom and other contraceptive use 
are consistently lower with emotional (non-paying) part-
ners.5 13 14 In many countries, particularly in sub-Saharan 
Africa, few FSWs use long-acting reversible contraceptives 
(intrauterine devices and implants), and methods such as 
injections, condoms and pills may be used inconsistently 
or incorrectly, rendering them less effective.5 15 Limited 
knowledge and misunderstandings, particularly in rela-
tion to contraceptive side effects and impacts on fertility, 
are significant demand-side barriers to contraceptive 
uptake.4 5 16
Family planning services are often neglected as part of 
FSW-specific service provision, which have focused largely 
on preventing HIV and other sexually transmitted infec-
tions (STIs).12 17–19 Stigma of health workers towards sex 
workers can also limit access to contraception.20 21 FSWs 
have the same reproductive rights as all women, and their 
desires and needs in relation to pregnancy have often 
been neglected,22–24 similar to other marginalised popu-
lations, which have historically been subjected to repro-
ductive coercion.25 26 It is important that those who do 
desire pregnancy are provided with non-judgemental 
care and that those who do not are given the opportu-
nity and resources to prevent it. Moreover, many FSWs 
who become pregnant may be reluctant to enter maternal 
health services, given their previous experiences of 
discrimination and abuse from health workers.20 FSW 
programmes need to make concerted efforts to facilitate 
timely attendance of FSW at antenatal clinic and child-
birth services. Importantly, FSWs often have remarkably 
high levels of HIV, and maternal health services are a key 
entry point for them to access antiretroviral treatment, 
which secures their health and reduces HIV in infants.
Despite a clear rationale for addressing unintended 
pregnancy in this population, it is important to acknowl-
edge that intention is a problematic concept, which 
is more accurately represented as a spectrum than a 
dichotomy.3 27 Indeed, many women feel positive about 
pregnancy despite not intending to conceive, or may 
simultaneously desire both pregnancy and its avoidance, 
for different reasons. The degree to which women accept 
or welcome a pregnancy once it has occurred has been 
hypothesised to be a more important predictor of adverse 
outcomes than prepregnancy intentions.27 Fertility pref-
erences are also likely to be less stable over time in LMICs 
undergoing fertility transition compared with high-in-
come countries.3 FSWs’ intentions also differ between 
types of partner, requiring them to adapt contraceptive 
use accordingly.22 Furthermore, as a stigmatised group, 
FSWs may feel pressure not to disclose their intention. 
Despite these limitations, we have continued to use the 
term ‘unintended pregnancy’ in this paper for the sake of 
consistency with other literature and the lack of a feasible 
alternative.
The primary objective of this study was to determine 
the pooled incidence of unintended pregnancy among 
FSWs in LMICs. Given the expected low number of 
eligible studies, we also aimed to determine the incidence 
of pregnancy where intention is not known. Secondary 
aims were to examine the correlates and predictors of 
pregnancy and the incidence of induced abortion and 
childbirth in this population.
MEthODs
All stages of this systematic review and meta-analysis have 
been reported in line with the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses statement.28 
The protocol for this review was registered with the inter-
national prospective register of systematic reviews (PROS-
PERO): number CRD42016029185.
Inclusion and exclusion criteria
Studies were included if they met key criteria in terms 
of population, outcomes and study design. FSWs had to 
account for at least two-thirds of the sample, unless data 
could be disaggregated by sex work status. We employed 
a broad definition of sex work, including women who 
self-identified as sex workers, those who engaged in 
transactional sex or part-time sex work and communi-
ties of women known to practice commercial or transac-
tional sex. Study participants had to live or work in an 
LMIC29 and be of reproductive age (15–49 years). Studies 
targeting women with reduced fertility (eg, women in 
the first 6 months postpartum and those exclusively 
breast feeding or undergoing fertility treatment) were 
excluded.
Studies had to measure or report one of the following 
primary outcomes:
1. Cumulative incidence (proportion of women who be-
came pregnant in a defined time period) or incidence 
rate (per person-time) of unintended pregnancy.
2. Cumulative incidence or incidence rate of pregnancy 
(where intention is not measured).
Unintended pregnancy was defined as any pregnancy 
considered by the woman to be not planned, intended 
or desired at the time of conception,30 as reported either 
prior to pregnancy or retrospectively. Such pregnan-
cies may be described by the authors as unintended, 
unwanted, undesired, unplanned or mistimed.
Any study design that was able to measure one or more of 
the primary outcomes was considered, including both obser-
vational and intervention studies. Case studies, ecological 
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studies, qualitative studies, editorials and commentaries 
were excluded. We planned to expand the inclusion criteria 
if insufficient studies measuring the primary outcomes were 
identified to include studies reporting prevalence of preg-
nancy in the previous 12 months. Cross-sectional studies 
were included in the initial screen for this purpose but were 
subsequently excluded as there were sufficient longitudinal 
studies measuring incidence. The addition of period prev-
alence in the last 12 months as an outcome would have 
required additional subanalyses; in addition, measurement 
of retrospective pregnancy intention in cross-sectional 
studies differs from prospective measurement as women 
may change their minds during the course of their preg-
nancy. Only studies published in English since 1 January 
2000 were included.
search strategy
A systematic electronic search of MEDLINE, Embase, 
PsychINFO and Popline was undertaken to identify rele-
vant peer-reviewed articles. Search syntax included, as both 
subject headings and keywords: synonyms for ‘sex work’; 
list of LMICs from the World Bank29 and synonyms for 
‘low- and middle-income’; and study design and descriptor 
terms, for example, ‘cohort studies’ or ‘controlled trials’ 
(full search strategy in online supplementary file).
A search for unpublished grey literature was also under-
taken, including conference proceedings and abstracts (via 
Web of Science and Proquest databases), research theses 
and the websites of relevant non-government organisa-
tions, including the Population Council, FHI 360 and Gutt-
macher Institute.
The last search was performed on 20 January 2016. Up 
to two attempts were made to contact authors when further 
information was required. Eligible studies recommended 
by contacted authors were also included.
screening and data extraction
Screening of all abstracts, removal of duplicates and selec-
tion of full-text articles was conducted by one researcher, 
with a random selection of 10% screened in duplicate. Data 
from a random sample of 50% of included full-text manu-
scripts were extracted in duplicate. Discrepancies in eligi-
bility and data extraction were resolved by discussion, with 
a third researcher arbitrating when necessary.
Summary estimates were sought rather than individual 
subject data. Data were extracted relating to: eligibility 
criteria; study aims, population and methods; setting 
and participant characteristics at baseline; primary and 
secondary outcome data for each time point reported; 
and quality assessment criteria. In addition to the primary 
outcomes, the following secondary outcomes were 
extracted: incidence of induced abortion (termination 
of pregnancy); incidence of birth; and correlates/predic-
tors of pregnancy or unintended pregnancy. Authors were 
contacted to provide data relating to the primary outcome 
when it was not reported in the paper, for example, the 
total person-years of exposure.
Quality assessment
Methodological quality of the included studies was assessed 
using a modified version of the Joanna Briggs Institute 
Prevalence Critical Appraisal Tool31 (online supplementary 
file). This tool was designed to assess studies measuring 
prevalence or incidence and can be applied to multiple 
study designs. The tool was modified to address specific 
methodological concerns of our research question. Given 
measurement bias could result from infrequent or irreg-
ular pregnancy detection methods, items on these methods 
were specifically included. We also documented whether 
pregnancy incidence was an a priori study objective.
Quality assessment was undertaken in duplicate for 50% 
of studies, with discrepancies resolved by discussion. Studies 
were given a score out of 15 if they measured unintended 
pregnancy incidence, and a score out of 14 if they measured 
pregnancy incidence (the latter did not include an item on 
measurement of intention). Scores were then reported as 
percentages.
Analysis
We undertook a qualitative narrative synthesis of both 
primary and secondary outcomes and quantitative anal-
ysis of primary outcomes using Stata V.13.1.
Incidence rate (per 100 person-years) was taken as 
the unit of analysis. In studies reporting only cumulative 
incidence, we estimated person-time, censoring women 
at their first pregnancy and assuming that they became 
pregnant halfway through the study.
The Mantel-Haenszel I2 statistic was over 95% for 
both primary outcomes, so meta-analysis and meta-re-
gression were not performed for all eligible studies, as 
had been planned. Instead, sources of heterogeneity 
were explored using subgroup analyses, and pooled 
incidence rates were calculated using DerSimonian & 
Laird random effects models for subgroups containing 
more than two studies and with I2 of less than 75%. The 
explored subgroups were clustered as covariates that may 
explain heterogeneity (geographic region and interven-
tion vs non-intervention) and potential methodological 
explanations of heterogeneity: study design (cohort vs 
randomised controlled trial (RCT); study duration; and 
frequency of pregnancy measurement (measured regu-
larly vs only when indicated). Interventions included 
any introduced by the study with the aim of improving 
sexual and reproductive health, including contraceptive 
provision and behavioural or biomedical interventions to 
prevent HIV/STIs.
We assessed study quality as a source of heterogeneity 
by examining scatter plots and Pearson correlation coef-
ficients of quality score against incidence rate. We also 
qualitatively explored characteristics of different studies, 
including the following baseline population charac-
teristics that may have impacted on pregnancy rates: 
age; contraceptive prevalence; consistent condom use; 
number of sex partners; coital frequency; STI prevalence; 
indicators of gender-based violence; and alcohol and 
other drug use.
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Patient and public involvement
The research question and outcome measures were 
informed by previous qualitative work with FSWs 
conducted by the International Centre for Reproductive 
Health, Kenya. This confirmed that unintended preg-
nancy was an important issue for this population group. 
Patients and members of the public were not otherwise 
involved in the design or conduct of this study.
rEsults
The initial search yielded 6523 peer-reviewed and 118 grey 
literature articles and 11 identified by hand-searching 
(eg, due to recommendations from contacted authors). 
After removal of duplicates, this resulted in 3866 articles 
(figure 1). Based on title and abstracts, 750 manuscripts 
remained for full-text screening.
Pregnancy incidence was reported in 12 studies and was 
obtained for a further 13 studies after contacting authors. 
These 25 studies were reported in 99 papers. Ten studies 
measured unintended pregnancy (outcome 1), and 15 
studies measured pregnancy without specifying intention 
(outcome 2); none measured both outcomes.
Fourteen cohort studies and 11 RCTs were included 
(table 1). Pregnancy incidence was not an a priori 
primary objective for any but was a secondary objec-
tive for a Rwandan HIV incidence study.32 The majority 
of studies aimed to test interventions to prevent HIV 
or STIs (n=11) or measure HIV incidence (n=8). Six 
undertook substudies in which they reported preg-
nancy incidence.33–38 Thirteen studies included any 
intervention: three involved provision of diaphragms or 
female condoms,39–41 and 10 studies were biomedical or 
behavioural interventions to prevent HIV/STIs (table 1). 
The latter included four studies that reported providing 
contraceptive counselling35 36 42 43 and one which offered 
free contraception when needed.44
Most RCTs in this review required women to remain 
non-pregnant for continuation.36 40 42 44–48 The majority 
of studies (n=19) took place in sub-Saharan Africa, 
most frequently in Kenya (n=8; table 1). There were 
also studies from the Americas (Mexico and the Carib-
bean) and East Asia (China, Thailand and Cambodia). 
All except three36 44 49 took place in urban settings. The 
study areas were frequently informal housing settlements, 
low-income areas or environments known for sex work 
and/or drug use.
Sex work was mainly defined as exchange of sex for 
money or goods (n=12) or money alone (n=4). In five 
studies, sex workers were self-identified, in two studies 
they were members of communities or working in areas 
known for commercial sex work36 46 and in two studies no 
definition was provided.48 50 Eighteen studies involved 
FSWs exclusively; the remainder targeted women with 
high-risk sexual practices or at high risk of HIV. These 
studies either reported pregnancy incidence in the sex 
work subgroup36 42 44 51 or FSWs constituted more than 
Figure 1 PRISMA flow diagram of search results and inclusion of studies after review.28 FSWs, female sex workers; LMICs, 
low-income and middle-income countries; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
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two-thirds of the sample.32 40 49 52 Fourteen studies were 
restricted to women without HIV at baseline, and one 
study to women living with HIV.37
Most studies (n=15) were conducted for 1–2 years, 
although they ranged from a 1 month pilot RCT40 to a 
15-year open cohort study.37 The studies reporting preg-
nancy (intention undefined) tended to be of longer dura-
tion than those reporting unintended pregnancy (median 
duration 24 and 12 months, respectively; table 2).
baseline population characteristics
Most study populations had a median of 5–8 years of 
education, and the majority of women were supporting 
at least one financial dependent (data not shown). 
Median duration in sex work was 3–5 years for most 
study populations, with one notable exception of 14 
years in a study in Mexico.43 Concurrent non-paying 
sex partners were common, reported by 30%–100% of 
women in 12 studies.
Permanent and long-acting reversible contraceptive use 
was around 1% in most studies in Africa, with only one 
study in Kenya reporting significantly higher coverage 
(17.5%).50 By contrast, coverage of these methods was 
greater than 30% in China53 and Mexico.43 54 Consistent 
condom use was measured using diverse metrics but was 
generally low and very low with non-paying partners. Most 
studies reported frequent sex with multiple partners, 
and few reported a median of less than five partners per 
week.37 45 52 55 High rates of gender-based violence were 
noted in all studies in which this was measured, as well 
as physical or financial pressure not to use condoms.40 56
While the factors described generally contributed to 
high baseline pregnancy risk, several studies included 
FSW with notably lower risk profiles. For example, two 
studies were part of a large Kenyan open cohort, in which 
participants had few partners and sex acts per work, 
and older median age and lower STI prevalence than 
the other studies.37 45 In addition, a number of studies 
provided insufficient information to assess population 
risk for pregnancy.
HIV prevalence was reported in four studies and 
varied from 24 % in Kenya 50 to less than 3 % in Mexico 
54 and Dominican Republic. 41  STIs other than HIV 
were prevalent, with one study reporting up to 36% of 
the study population having at least one STI on biolog-
ical testing.35 57 
Methodology and quality assessment
Quality scores, as percentages of the available total, are 
presented in table 2. The median quality score was 40% 
(IQR=36%–50%). Four studies scored 60% or greater; 
three of these measured unintended pregnancy32–34 and 
one measured pregnancy (undefined).53 Most studies 
scored poorly in the external validity and selection bias 
categories.
Measurement bias was an issue for some studies. Preg-
nancy was tested regularly in all but one44 of the unin-
tended pregnancy studies; in contrast, five pregnancy 
(undefined) studies only measured it if suspected 
by the clinician or participant. Five of the pregnancy 
(undefined) studies measured pregnancy using self-re-
port rather than a biological test.
Incidence of pregnancy
Incidence rate was reported by 14 studies and calculated 
for the remainder based on the available data, with the 
number of women who became pregnant as the numer-
ator and person-years as the denominator. Women were 
censored at the time they became pregnant. The one 
exception was Deschamps et al,33 who counted multiple 
pregnancies and subtracted pregnancy time from total 
person-time.
Unintended pregnancy incidence rate (outcome 1) 
varied widely between studies, ranging from 7.2 to 59.6 
pregnancies per 100 person-years (table 2; figure 2). 
The median rate of the 10 studies was 26.8, and seven 
reported a rate of greater than 20 per 100 person-years.
Incidence rate of pregnancy (intention undefined – 
outcome 2) also varied widely, but rates were lower overall 
than unintended pregnancy, ranging from 2.0 to 23.4 
per 100 person-years (table 2). The median rate of the 15 
studies was 13.5, and only two reported a rate of greater 
than 20 per 100 person-years.
Meta-analyses
Random effects meta-analyses were performed for the two 
primary outcomes. Heterogeneity was high, with I2 statistic 
over 95% for both outcomes.
Incidence of unintended pregnancy
Explored covariates that may explain the high heteroge-
neity of unintended pregnancy incidence showed that 
geographical region did not explain this, whereas pres-
ence/absence of an intervention seemed important. The 
three cohort studies that did not involve an intervention 
had very low heterogeneity (I2=0%), and the pooled esti-
mate for these studies was 27.1 unintended pregnancies 
per 100 person-years (95% CI 24.4 to 29.8; figure 3). These 
three studies scored at least 60% on quality assessment 
(table 2).
Assessment of potential methodological explanations 
showed that study design (RCT vs cohort) and study dura-
tion seemed important sources of heterogeneity, while 
pregnancy measurement method did not explain the high 
heterogeneity. The cohort studies were more homogenous 
than the RCTs (I2=63.9% and 96.8% respectively), and 
had higher pooled incidence of unintended pregnancy 
(figure 4). The three studies of less than 1 year duration 
were more homogenous (I2=59.1%) and had higher inci-
dence (44.5 per 100 person-years) than longer studies 
(figure 5).
Quality was not found to be a source of heterogeneity, 
as no relationship was demonstrated between study quality 
score and unintended pregnancy incidence rate (Pearson 
correlation coefficient 0.01; scatter plot not shown).
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Table 2 Results of included studies reporting unintended pregnancy and pregnancy (intention undefined) in ascending order 
of incidence
Study
Incidence 
rate (per 100 
person-years) 95% CI
Person-
years of 
exposure
Duration 
(months)
Measurement 
of pregnancy
Frequency of 
measurement
Quality 
(%)
Unintended pregnancy
  McClelland 
  et al77
7.2 4.5 to 10.9 305.4 12 Urine test Monthly 40
  Watson-Jones 
  et al44
11.8 9.7 to 14.5 796 30 Urine test Quarterly on suspicion 
only
53
  Gaffoor
  et al42
13.4 6.1 to 25.4 67.2 24 Urine test Quarterly 20
  Behets 
  et al40
20.7 4.3 to 60.5 14.5 1 Urine test Weekly 27
  Braunstein 
  et al32
26.3 21.9 to 30.7 528.5 24 Serum test 6 monthly for 
1 year+1 measurement 
in second year
60
  Deschamps 
  et al33
27.3 23.3 to 31.7 615.6 18 Test 
(unspecified)
6 monthly 67
  Chersich 
  et al34
28.0 22.6 to 34.3 335.8 12 Urine test Quarterly 60
  Peterson 
  et al46
51.7 44.9 to 59.3 400 12 Urine test Monthly 40
  Behets 
  et al39
53.0 21.0 to 110.0 13.2 2 Urine test Monthly 40
  Lara 
  et al41
59.6 41.7 to 82.5 60.4 4 Urine test Monthly 40
Pregnancy (intention undefined)
  Robb 
  et al51 
2.0 1.4 to 2.9 1619.6 24 Self-report Quarterly on suspicion 
only
21
  McClelland
  et al37
2.7 2.1 to 3.5 2259.3 15-year 
open 
cohort *
Urine test Monthly on suspicion 
only
21
  Bazzi 
  et al54 
3.3 1.4 to 5.2 359.6 24 Self-report 6 monthly 43
  Strathdee 
  et al43
5.9 4.1 to 8.4 540.1 12 Self-report 4 monthly 36
  van 
Loggerenberg 
  et al52
8.5 5.6 to 11.5 376.5 24 Urine test Monthly on suspicion 
only
36
  Van Damme 
  et al48
8.6 6.7 to 10.8 837.5 ≤24* Urine test Quarterly 29
  Vielot 
  et al50
12.6 9.7 to 16.1 500.8 24 Urine test Quarterly on suspicion 
only
50
  Kaul 
  et al47
13.5 11.3 to 16.1 968.0 ≤48* N/A N/A 21
  Priddy 
  et al56
14.2 7.6 to 24.3 91.5 6 Urine test Quarterly 36
  Price 
  et al49
14.5 12.0 to 17.5 784.0 48 Urine test Quarterly 43
  Liu
  et al53
15.2 10.4 to 21.5 210.3 6 Self-report Quarterly 71
  Kaewkungwal 
  et al36
15.8 13.0 to 19.0 721.0† 42 Urine test N/A 43
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Incidence of pregnancy (intention undefined)
Subgroup analyses showed that study duration and 
geographic region were sources of heterogeneity for rates 
of pregnancy where intention was not known. Pregnancy 
measurement method and study design characteristics 
did not account for any heterogeneity for this outcome.
There were only two studies of less than 1-year dura-
tion53 56 (I2 0%). As with the unintended pregnancy 
outcome, these studies had a higher pooled incidence 
than studies of more than 1 year duration (14.9 vs 11.4 
per 100 person-years).
A subanalysis of geographic region showed that studies 
from Asia and the Americas (both in Mexico) were more 
homogenous (I2=29.8% and 68.1%, respectively) than 
those from sub-Saharan Africa (I2=98.3%). The pooled 
incidence of pregnancy was higher in Asia (16.8 per 100 
person-years) and lower in Mexico (4.8 per 100 person-
years; figure 6).
A scatter plot demonstrated a weak positive relation-
ship between quality score and incidence rate (plot not 
shown; Pearson correlation coefficient 0.55).
secondary outcomes
Three studies assessed pregnancy outcomes for FSWs 
(table 3). In two of the studies, outcomes were unknown 
for about 25% of pregnancies (in the Caribbean33 and 
Madagascar,35) resulting in underestimates of birth and 
abortion incidence. Abortion accounted for less than 
20% of pregnancies with known outcomes. In contrast, in 
the third study, a multicountry study,48 62 abortions were 
recorded as adverse events (author correspondence), 
compared with only 10 reported as withdrawing from the 
Study
Incidence 
rate (per 100 
person-years) 95% CI
Person-
years of 
exposure
Duration 
(months)
Measurement 
of pregnancy
Frequency of 
measurement
Quality 
(%)
  Vandepitte 
  et al93
18.3 16.2 to 20.6 1467.0 ≥24* Urine test N/A 50
  Page et al38 22.0 16.3 to 30.1 186.4 12 Self-report Quarterly 50
  Feldblum 
  et al35
23.4 20.6 to 26.5 1067.5 18 Urine test 6 monthly on 
suspicion only
43
*Duration varied for different participants.
†Person-time estimated by: (n_FSWs * yrs * retention) − (n_preg * yrs/2); where: n_FSWs, number of FSWs enrolled; yrs, study duration in 
years; retention, retention  rate; n_p reg, number of women who became pregnant. We could not use the approach advocated by Vandenbrou 
c ke et al 95 as average follow-up time among FSWs was not known. 
FSWs, female sex workers; N/A, not measured or reported, data not available from author.
Table 2 Continued 
Figure 2 Incidence rates (per 100 person-years) for studies reporting unintended pregnancy.
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study due to pregnancy, suggesting that over 85% of the 
total women who became pregnant reported an abortion.
Four studies developed multivariate regression models 
to determine the predictors of pregnancy35 37 or unin-
tended pregnancy.5 33 Common findings were that 
younger age was associated with higher pregnancy inci-
dence5 33 35 and that highly effective contraceptive use35 
and consistent condom use35 37 were protective; however, 
one study in Kenya found that using condoms at the 
exclusion of other methods was a risk factor.5 Having a 
Figure 3 Forest plot showing subgroup analysis of unintended pregnancy incidence rates (per 100 person-years) by 
intervention versus no intervention.
Figure 4 Forest plot showing subgroup analysis of unintended pregnancy incidence rates (per 100 person-years) by RCT 
versus cohort study design. RCT, randomised controlled study.
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main or emotional partner increased the odds of unin-
tended pregnancy5 33 but not of pregnancy (intention 
undefined).35 37 Deschamps et al noted some additional 
associations, including recreational drug use and male 
partners having other sex partners being protective 
against pregnancy. Only one study assessed reproductive 
Figure 5 Forest plot showing subgroup analysis of unintended pregnancy incidence rates (per 100 person-years) by study 
duration (cut-off 1 year).
Figure 6 Forest plot showing subgroup analysis of pregnancy (intention undefined) incidence rates (per 100 person-years) by 
geographic region.
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history and income,5 and none considered HIV status as 
potential predictors or confounders.
DIsCussIOn
This review found that of the many studies examining 
FSWs’ sexual and reproductive health in LMICs, very few 
have measured pregnancy and even fewer have assessed 
pregnancy intention. While incidence varies widely 
between the included studies, it is sufficiently high in 
most low-income and middle-income contexts to consti-
tute a significant health and social issue for FSWs.
Study design impacted on unintended pregnancy rates, 
with a lower rate seen in RCTs (20.8 per 100 person-years) 
than cohort studies (29.6 per 100 person-years). Most 
of the RCTs in this review required women to remain 
non-pregnant for continuation36 40 42 44–48 and although 
only six RCTs specifically mentioned providing contra-
ceptive counselling or methods, others may have offered 
a larger package of services that was not reported.
To better understand the influence of services provided 
by studies, we compared studies that provided any inter-
vention with those that did not and found that the three 
studies in the latter category had very low heterogeneity 
and high pooled unintended pregnancy incidence (27 
per 100 person-years). As non-intervention cohort studies 
with quality scores of at least 60%, these were arguably the 
best designed to answer the review question.
The included studies may have underestimated popu-
lation incidence of pregnancy, for several reasons. First, 
studies that only tested for pregnancy on suspicion could 
have missed early pregnancies or failed to ascertain the 
need to test. Second, pregnancies occurring between 
study visits and ending in spontaneous or induced abor-
tion may have been missed. Third, social desirability 
bias is likely to influence self-reporting of pregnancy in 
studies using that measure. Fourth, participants may have 
joined some studies in order to access services, poten-
tially receiving superior family planning services than 
would otherwise be accessible.58 Finally, there may be 
selective loss to follow-up among women who become 
pregnant, particularly in drug trials requiring women 
to remain non-pregnant for continuation.36 40 42 44–48 It is 
possible that these factors were more prominent in the 
studies measuring pregnancy without defining intention, 
contributing to the surprising finding that this outcome 
had generally lower incidence rates than unintended 
pregnancy.
Some ‘unintended’ pregnancies may in fact have been 
intended, because women may have been unsure about 
their intention or it changed over time.27 Only one study 
assessed intention repeatedly,34 and none used a validated 
instrument designed to measure this complex latent 
construct.59 Some participants may have wanted a preg-
nancy but felt pressure to say otherwise, depending on 
the social environment, external and internal stigma and 
the study design, for example, if they wanted to access 
HIV prevention and other services through the study 
but inclusion was restricted to those not wanting to get 
pregnant.
Conversely, it is likely that most women in the unde-
fined intention category (outcome 2) who became preg-
nant may not have intended to do so. During recruitment 
for a pregnancy prevention intervention trial with FSWs 
in Kenya,6 less than 1% of those interested in taking part 
were planning to get pregnant in the next year (unpub-
lished data). Similarly, in a cohort study included in 
this review, only 4% of participants expressed an inten-
tion to get pregnant at some point during the 12-month 
follow-up.5 34 A study in South Africa found a higher 
proportion (10%) wishing to conceive, but this is still 
a small minority of FSWs. While immediate pregnancy 
intentions may be low, however, future fertility pref-
erences may be comparable with other women,60 and 
several authors have highlighted the need for appropriate 
services that promote safe conception and address FSWs’ 
need for different forms of protection with different part-
ners.22–24 60
Quality scores were low, but it is important to note 
that we were assessing how well the studies answered our 
research question, rather than their own stated objectives. 
However, there was a notable absence of well-described 
sampling and recruitment techniques, suggesting that 
Table 3 Incidence of abortion and birth
Study Site Outcome
Incidence of 
pregnancy
Incidence of 
birth
Incidence 
of abortion
Abortion (as 
proportion of 
pregnancies with 
known outcome)
Deschamps et al33 Haiti, Puerto 
Rico and Dominican 
Republic
Unintended 
pregnancy
27.3 15.1 3.1 16%
Feldblum et al35 Madagascar Pregnancy 
(intention 
undefined)
23.4 11.9 3.0 17%
Van Damme et al48 Benin, Cote d’Ivoire, 
South Africa and 
Thailand
Pregnancy 
(intention 
undefined)
8.6 Not measured 7.4 >85%
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study populations may have been poorly representative 
of local FSW populations. This may have underestimated 
pregnancy incidence, as more marginalised members 
of the population, who are at greater sexual risk, are 
harder to reach and recruit by convenience or snowball 
methods. Indeed, the only study to use a random sampling 
approach found moderately high incidence of pregnancy 
(intention undefined; 15 per 100 person-years), despite 
30% IUD coverage in this population.53 Furthermore, 
inclusion criteria limiting more than half of the studies 
to HIV negative women contributed to selection bias, 
particularly in sub-Saharan African studies, where HIV 
prevalence among FSWs is estimated at 37%.61 This may 
partly explain the observation that pregnancy incidence 
in sub-Saharan Africa was lower than Asia, despite the 
fact that total population fertility rates are lower in Asia. 
Higher quality scores seen in the Asian studies may also 
account for this discrepancy.
Quantitative analysis identified study duration as a clear 
contributor to heterogeneity in both outcomes. Incidence 
was lower in shorter studies and decreased over time 
within studies that reported incidence at multiple time 
points.32 35 This is due in part to the analytical approach, 
taken by all but one study,33 of censoring women’s person-
time when they first become pregnant. As study subjects 
at highest risk fall pregnant early, they are censored early 
and cannot contribute additional pregnancies to the 
numerator. The remaining lower risk women are less 
likely to experience the outcome. The same phenomenon 
has been observed in closed cohorts with the outcome of 
HIV incidence.62 In addition, sexual risk behaviours often 
reduce over time in longitudinal studies, because of social 
desirability bias or health education from study participa-
tion,33 36 or attrition bias,63 which may have been a factor 
for 12 studies in this review with low or unreported reten-
tion rates among FSWs.
While measurement bias did not emerge as a signifi-
cant source of heterogeneity, there was ambiguity in the 
reporting of pregnancy measurement, and it was often 
dependent on authors’ recollections. There was a weak 
positive association between study quality and incidence 
rates in the pregnancy (intention undefined) group. The 
lack of a clear relationship may be because quality issues 
can result in either an underestimate or overestimate of 
incidence.
limitations
This review had a number of limitations. Foremost was 
the inclusion of studies in which (unintended) preg-
nancy incidence was not an a priori objective, which was 
the case for all but one. This likely resulted in method-
ological issues affecting participant selection and preg-
nancy measurement.
We also adopted a broad approach to other inclusion 
criteria. Several studies conducted in the late 1990s and 
early 2000s were included, which may be problematic as 
family planning coverage has grown and fertility rates 
declined since that time. The heavy reliance on authors 
to provide unreported data was a limitation and may 
have introduced bias, and older data often could not 
be accessed.
We used a broad definition of sex work, which may 
have increased the heterogeneity of the outcomes. 
However, this definition reflects the reality that there 
are many reasons for women to sell sex, which depend 
on local laws, culture and economies, and to arbi-
trarily limit to full-time sex workers, for example, may 
exclude studies of ‘hidden’ FSWs who are often espe-
cially vulnerable.64 65
Our analysis was limited by high heterogeneity, 
which prevented us from pooling overall rates or 
performing meta-regression to tease out the influence 
of different variables. Heterogeneity was not fully 
explained by explorative subanalyses and may in part 
be due to the low number of studies, low quality and 
incomplete data on risk factors. It should be noted 
that interpretation of these descriptive heterogeneity 
statistics require a certain level of caution, specifi-
cally where the number of cases is small. Variations 
in baseline population risk probably contributed 
significantly to heterogeneity, but these could not be 
quantified due to the incomplete and/or inconsistent 
measurement of risk factors between studies. Cultural, 
legal and economic contexts, such as cultural norms 
around motherhood and abortion law, also vary 
considerably between the different settings in which 
the studies took place, and influence fertility prefer-
ences, expression of pregnancy intention and access 
to prevention methods and abortion. These contex-
tual factors could not be accounted for in our analysis.
Another limitation was that we were unable to 
directly compare rates of pregnancy between FSWs 
and other populations. Very high pregnancy inci-
dence has been observed in HIV studies among 
women not categorised as sex workers66 67; however, 
these women were at high risk for HIV for other 
reasons (eg, multiple partners). Among the general 
population, unintended pregnancy incidence is esti-
mated at 5.4 per 100 person-years in the developing 
world, and eight in Africa,68 substantially lower than 
the rates among FSWs presented here. Of the three 
studies in this review, which reported incidence for a 
broader study population as well as an FSW subgroup, 
two reported higher incidence36 42 and one reported 
approximately equal incidence44 in the FSW subgroup 
compared with the whole study population.
COnClusIOn
Ultimately, this review demonstrates a concerning 
lack of research on an issue which is a priority for 
many FSWs in low-resource settings. This is surprising 
as we found many studies on HIV incidence and 
prevention in this population, for which unintended 
pregnancy is both relevant to the primary outcome 
and may indicate overall sexual risk. There has been 
 on N
ovem
ber 5, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2018-021779 on 17 S
eptem
ber 2018. D
ow
nloaded from
 
16 Ampt FH, et al. BMJ Open 2018;8:e021779. doi:10.1136/bmjopen-2018-021779
Open access 
a modest increase in family planning availability for 
women in many countries since the early 2000s69 70; 
however, this has not been accompanied by research 
on whether these additional services have reached 
FSW populations or impacted on pregnancy rates. 
Access to family planning, particularly long-acting 
reversible contraceptives, may be improved by better 
targeting of FSWs through mobile outreach71 and 
integration with existing FSW-specific HIV prevention 
services, and by careful training of health workers 
and community workers in contraceptive counselling 
and follow-up.71 Also, it is important that concerted 
efforts are made to link FSWs who become pregnant 
with maternal health services, including services for 
antiretroviral treatment and preventing HIV transmis-
sion to infants.
This review found that studies measuring pregnancy 
incidence among FSWs were of low overall methodolog-
ical quality and had highly varied results but that unin-
tended pregnancy incidence was high overall and, based 
on available data, higher than the general population. 
There is an urgent need for quality research on unin-
tended pregnancy incidence, the effectiveness of inter-
ventions to reduce it and the best models of reproductive 
health service provision for this large and stigmatised 
population.
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